Literature DB >> 31531545

Prevalence of cataract complications in patients with pseudoexfoliation syndrome in Northwestern Spain.

Pedro Vazquez-Ferreiro1,2, Francisco J Carrera-Hueso3, Lidia Barreiro-Rodriguez1, Marta Diaz-Rey1, Jaime E Poquet Jornet4.   

Abstract

PURPOSE: To assess the relationship between pseudoexfoliation syndrome and incidence of complications and related clinical factors in patients undergoing cataract surgery.
METHODS: We conducted a retrospective cohort study of 503 of 551 patients who underwent phacoemulsification surgery over 2 years in a health care district in Northwest Spain. In total, 120 of 681 eyes undergoing the procedure had pseudoexfoliation syndrome. Data on the surgical procedure and associated complications were extracted from the medical record. Complications included any combination of posterior capsular rupture, vitreous loss, zonular dialysis, and nuclear or lens luxation.
RESULTS: We found a significant association between pseudoexfoliation syndrome and zonular dialysis (odds ratio [OR], 6.89; 95% CI, 2.27-20.93), intraoperative miosis (OR, 2.15; 95% CI, 1.10-4.22), and lens luxation >1.5 mm (OR, 9.49; 95% CI, 0.85-105.54). However, when adjusting for the overall risk of complications in pseudoexfoliation syndrome patients in consideration of myopia, use of anticoagulants or α-agonists, previous mydriasis, and anterior chamber length, the OR decreased to 1.02 (95% CI, 0.47-2.21) and was therefore not significant.
CONCLUSION: Zonular dialysis and intraoperative miosis were intraoperative complications in cataract surgery patients with pseudoexfoliation syndrome when compared to controls.

Entities:  

Year:  2019        PMID: 31531545     DOI: 10.5935/0004-2749.20190095

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  1 in total

1.  Exfoliation Syndrome in Egypt: Prevalence and Association with Cataract in a Large Cohort.

Authors:  Bassem Fayez Aziz; Amr Ismail Elawamry; Maged Maher Roshdy; Caroline Atef Tawfik
Journal:  Ophthalmol Ther       Date:  2021-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.